SageView Advisory Group’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,264
Closed -$5.51K 1311
2025
Q4
$5.51K Buy
+1,264
New +$6.83K ﹤0.01% 1944
2024
Q2
Sell
-18,788
Closed -$314K 600
2024
Q1
$314K Buy
+18,788
New +$171K 0.02% 401

Other funds holding GNLX

SageView Advisory Group's GNLX Position: Q1 2026 in Review

SageView Advisory Group sold out of Genelux (GNLX) in Q1 2026, closing a stake of 1,264 shares — an estimated $5.51K sold.

SageView Advisory Group first reported a position in GNLX in Q1 2024 and held it in 2 quarters. The position peaked at $314K in Q1 2024. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • SageView Advisory Group reported no remaining Genelux position as of Q1 2026 after selling out during the quarter.
  • SageView Advisory Group sold 1,264 Genelux shares in Q1 2026, an estimated $5.51K.
  • SageView Advisory Group first reported a position in Genelux in Q1 2024 and held it in 2 quarters.
  • SageView Advisory Group's Genelux position peaked at $314K in Q1 2024.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.